All PlansCoverageMedium impact
Noninvasive Techniques for the Evaluation and Monitoring of Patients With Chronic Liver Disease
Blue Cross & Blue Shield of Mississippi·MS · Gastroenterology, Internal Medicine, Family Medicine +1 more·Medical Policy
We identified it
Jun 20, 2026
Summary
This is a new medical policy defining coverage criteria for noninvasive liver fibrosis testing techniques as alternatives to liver biopsy for patients with chronic liver disease. The policy establishes guidelines for multianalyte serum assays and specialized radiologic methods for monitoring liver fibrosis in conditions like hepatitis C, hepatitis B, alcoholic liver disease, and NAFLD/MASLD.
Action Required
Immediately: Review current billing practices for liver fibrosis testing procedures to ensure compliance with new policy guidelines. Billing team should familiarize themselves with covered noninvasive testing options including FibroSURE tests and specialized imaging methods. Update prior authorization protocols if required for these services based on policy criteria.